SUMO1 and neoplasm: Our findings show that SUMO1 expression is significantly upregulated in AH-6809-treated LUAD cells, suggesting that AH-6809 may regulate apoptosis via SUMOylation, thereby inhibiting tumor growth (Ke et al., 2019).